Desk›Fast Moving Consumer Goods› India Glycols Ltd
India Glycols Ltd
BSE 500201 · NSE INDIAGLYCO · ISIN INE560A01023 · Group A · Active
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Beverages › Breweries & Distilleries
₹1,201.80
+0.95%
BSE close, 28 August 2026
₹8,055.28 cr
6.7 cr shares · Small cap
₹2,688.05 cr
as published
26.3× · 4.53×
EPS ₹45.66 · BV ₹265.30
9,826.20 / 282.33
₹ cr, as filed
52
11 selected · 21%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -1.7% |
|---|---|
| Against 52-week low | +51.4% |
| Day change | +0.95% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹45.66 |
|---|---|
| Price / earnings | 26.32× |
| Price / book | 4.53× |
| Book value — derived, price ÷ P/B | ₹265.30 |
| Return on equity | 17.22% |
| Operating margin | 5.70% |
| Net margin | 2.56% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 17.21%
- ROE as published
- 17.22%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 2,986.92 | 76.59 | 11.43 | 5.70% | 2.56% |
| Mar-26 · Q | 2,361.40 | 110.28 | 17.31 | 8.61% | 4.67% |
| FY25-26 | 9,826.20 | 282.33 | 44.31 | 7.01% | 2.87% |
Quarter on quarter
- Revenue, quarter on quarter
- +26.5%
- Net profit, quarter on quarter
- -30.5%
- Operating margin, quarter on quarter
- -291 bps
Disclosure profile 52 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Investor Presentation | 5 |
| Change in Management | 3 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Results | 1 |
| Selected sub-total | 11 |
| Procedural | |
| General | 23 |
| AGM / EGM | 4 |
| Analyst / Investor Meet | 3 |
| Clarification | 2 |
| Newspaper Publication | 2 |
| Trading Window | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Record Date | 1 |
| Procedural sub-total | 41 |
| Total | 52 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
52 filings · 11 selected · busiest 2026-08-19 and 2026-08-21
Filing rhythm · the twelve most recent
2026-09-072026-10-09
SelectedProcedural
Filings
52 in the window · 6 earlier on record
-
9 October 2026 ·
-
8 October 2026 ·
Clarification sought from India Glycols Ltd
The Exchange has sought clarification from India Glycols Ltd on October 08, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Company Update / Clarification
-
6 October 2026 ·
Apportionment Of Cost Of Acquisition Of Equity Shares Of India Glycols Limited ('Demerged Company'/'The Company'), Ennature Bio Pharma Limited ('Resulting Company 1') And IGL Spirits Limited ('Resulting Company 2') Pursuant To Scheme Of Arrangement Amongst The Company, Resulting Company 1 And Resulting Company 2 And Their Respective Shareholders ('Scheme'/'Scheme Of Arrangement')
Please find attached.
Company Update / General View filing →
-
6 October 2026 ·
Update On Analyst / Institutional Investor Meetings.
Please find attached.
Company Update / General View filing →
-
5 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Intimation Of Schedule Of Analyst / Institutional Investor Meeting.
Please find attached.
Company Update / General View filing →
-
28 September 2026 ·
Closure of Trading Window
Please find attached.
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Intimation Of Schedule Of Analyst / Institutional Investor Meeting.
Please find attached.
Company Update / General View filing →
-
16 September 2026 ·
Intimation Of Schedule Of Plant Visit By Investors/Analysts.
Please find attached.
Company Update / General View filing →
-
8 September 2026 ·
Material Update In Connection With Ennature Bio Pharma Limited
Please find attached
Company Update / General View filing →
-
8 September 2026 ·
Material Update In Connection With IGL Spirits Limited
Please find attached
Company Update / General View filing →
-
7 September 2026 ·
Intimation Of Schedule Of Analyst / Institutional Investor Meeting.
Please find attached
Company Update / General View filing →
-
7 September 2026 ·
500201 - Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.
Please find attached
Company Update / General View filing →
-
7 September 2026 ·
Material Update In Connection With IGL Spirits Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.
Please find attached
Company Update / General View filing →
-
2 September 2026 ·
Investor Presentation
Please find attached for Chemical Business.
Company Update / Investor Presentation View filing →
-
2 September 2026 ·
Investor Presentation
Please find attached for Chemical Business.
Company Update / Investor Presentation View filing →
-
2 September 2026 ·
Investor Presentation
Please find attached for Spirits and Bio Fuel.
Company Update / Investor Presentation View filing →
-
2 September 2026 ·
Investor Presentation
Please find attached for Ennature Bio Pharma.
Company Update / Investor Presentation View filing →
-
1 September 2026 ·
-
1 September 2026 ·
Effectiveness Of The Scheme Of Arrangement
Please find attached.
Company Update / General View filing →
-
28 August 2026 ·
Analyst / Investor Meet - Intimation
Please find attached.
Company Update / Analyst / Investor Meet View filing →
-
21 August 2026 ·
Material Update In Connection With IGL Spirits Limited With Reference To Observation Lefter No. NSE/LIST/48932 Dated 17T November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19" November, 2025 ("Observation Letters'), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges'), Respectively, Received In Relation To The Scheme Of Arrangement.
Please find attached.
Company Update / General View filing →
-
21 August 2026 ·
500201 - Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17T November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19" November, 2025 ("Observation Letters'), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges'), Respectively, Received In Relation To The Scheme Of Arrangement.
Please find attached.
Company Update / General View filing →
-
21 August 2026 ·
Fixation Of Effective Date And Record Date For Scheme Of Arrangement.
Please refer to attachment.
Corp. Action / Record Date View filing →
-
21 August 2026 ·
Fixation Of Effective Date And Record Date For Scheme Of Arrangement.
Please refer to attachment.
Company Update / General View filing →
-
21 August 2026 ·
-
20 August 2026 ·
Receipt Of Certified True Copy Of NCLT Order
Please find attached.
Company Update / General View filing →
-
20 August 2026 ·
Earnings Call Transcript
Please find attached.
Company Update / Earnings Call Transcript View filing →
-
19 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find attached.
AGM/EGM / AGM View filing →
-
19 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached.
AGM/EGM / AGM View filing →
-
19 August 2026 ·
Clarification On BSE Query On Volume Movement.
Please find attached.
Company Update / General View filing →
-
19 August 2026 ·
Clarification For NSE Query On Spurt In Volumes
Please find attached
Company Update / General View filing →
-
19 August 2026 ·
Clarification sought from India Glycols Ltd
The Exchange has sought clarification from India Glycols Ltd on August 19, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
14 August 2026 ·
Analyst / Investor Meet - Outcome
Please find attached
Company Update / Analyst / Investor Meet View filing →
-
14 August 2026 ·
-
13 August 2026 ·
Reminder For Mandatory Furnishing Of PAN, KYC Details And Nomination For Holders Of Physical Securities.
Please find attached
Company Update / General View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting
Please find attached.
Board Meeting / Outcome of Board Meeting View filing →
-
12 August 2026 ·
-
12 August 2026 ·
-
6 August 2026 ·
Intimation Of Q1FY27 Earnings Conference Call
Please find attached.
Company Update / General View filing →
-
6 August 2026 ·
Analyst / Investor Meet - Intimation
Please find attached.
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026 ·
Closure of Trading Window
Update on Closure of Trading Window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
5 August 2026 ·
Board Meeting Intimation for Consider And Approve The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The First Quarter Ended 30Th June, 2026.
India Glycols Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone ....
Board Meeting / Board Meeting View filing →
-
4 August 2026 ·
Material Update In Connection With IGL Spirits Limited (Wholly Owned Subsidiary) With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.
Please refer to attachment.
Company Update / General View filing →
-
31 July 2026 ·
Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.
Please find attached
Company Update / General View filing →
-
31 July 2026 ·
-
24 July 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Please find attached.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
24 July 2026 ·
-
24 July 2026 ·
Notice Of 42Nd Annual General Meeting, Annual Report For FY 2025-26 And Intimation Of E Voting Facility
Please find attached
AGM/EGM / AGM View filing →
-
23 July 2026 ·
-
22 July 2026 ·
-
20 July 2026 ·
RSS feed for India Glycols Ltd · the 50 most recent filings